Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: ted who wrote (146)	9/28/1998 2:10:00 AM
From: Mike McFarland	Read Replies (2) \| Respond to of 557

that comes from a Seattle Times article interviewing a UW researcher, not from the company Do you remember when that article came out? I could not find it with a quick search on the Seattletimes' website. Also, I think I had things all turned around and that we would not see anything more on AAV til next spring, but I see now that I was thinking of the paper on the HBV-specific CTLs (Additional data from the study is being collected and analyzed and a paper is expected to be submitted for publication in the first half of 1999). May have to go back and read some old posts. Hope you get a chuckle out of this: Since I cant seem to keep these details straight, maybe I have overactive blocker CREB, ha ha. I was reading this article in the Economist about memory in which this CREB memory thing is mentioned so I raced upstairs to the PC to find out if TGEN had "CREB" on it's plate too--took me a few minutes to find CREG (for cellular repressor of E1A-stimulated genes) in that article Reid linked to. Not exactly the same thing! I gotta keep my acronyms strait. --MM